Neurorehabilitation News

ORLANDO, Fla. — Patients with MS who developed paramagnetic rim lesions declined more rapidly, but implementing disease-modifying therapies earlier could reduce the burden of disease progression, data show.

A Korean study identified a 22% increased risk for seizure among young children who were prescribed first-generation antihistamines, according to findings published in JAMA Network Open.

ORLANDO, Fla. — In a cohort of South American young adults, those who smoked or vaped recorded lower scores on a cognitive assessment vs. those who did not, with a stronger correlation found between vapers and lower cognitive scores, data show.

The FDA has granted clearance to a Colorado-based medical technology company’s transcutaneous electrical nerve stimulation device for those suffering from chronic pain, according to a press release.

Compared with gross total resection, lobectomy as a surgical intervention for individuals with glioblastoma had a more positive impact on progression-free and overall survival outcomes, according to a systematic review and meta-analysis.

Plasma biomarkers shed light on concussion-related neuropathology in adolescents who played contact sports in Canada, supporting their use in pathophysiology, according to new research.

Topline data from an ongoing clinical trial of a higher dose regimen of Spinraza in treatment-naive, symptomatic infants with spinal muscular atrophy showed significantly improved motor function at 6 months.

A combination therapy led to significant dystrophin expression and functional improvement in patients with Duchenne muscular dystrophy amenable to exon 51 skipping, according to new data from a phase 1/2 clinical trial.

Transcranial static magnetic stimulation did not significantly modify ALS disease progression at 6 months compared with sham, but long-term follow up showed an increase in tracheostomy-free survival, data show.